Efflux Pump Inhibitor Restores Azithromycin Activity Against Multidrug-Resistant Pathogens

Reductions in Funding, Personnel Will Leave US Less Prepared for Future Infectious Disease Outbreaks

ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections

From Pathogen to Infectious Disease Diagnosis: cobas MPX-E adds HEV to NAT screening

ATB Finder Aims to Transform Antibiotic Selection by Replicating Real-World Infection Conditions

Treating the Andes Strain of the Hantavirus Associated With the Cruise Ship Cluster

SIDP President Outlines Priorities for Coming Year

Understanding the Nuances of Urine-Specific Breakpoints in Improving Antibiotic Stewardship

Aggressive Supportive Care is Key in Treating Ebola

The Mysterious Contagiousness of the Cruise Ship Strain of the Hantavirus

Understanding the Ongoing Ebola Outbreak

Viral Hepatitis Awareness Month Highlights Need for Testing for Individuals With SUD

Rising Threat of Metallo-Beta-Lactamases Drives Demand for Novel Therapeutics

Preclinical Models Provide Critical Foundation for Antibiotic PK/PD Targets

MAD-ID and SIDP Launching a New Conference Named Antimicrobials

Advocating for Personalized OPAT Monitoring to Improve Patient Care

SIDP and MAD-ID Partnership Aims to Expand Access and Collaboration in Infectious Diseases Education

For Young Clinicians, Learning How to Navigate New Research Projects

Antibiotic Duration, Treatment Considerations for Lyme Disease in Pediatric Population

Addressing the Shifting Changes in Substance Use Disorder Patterns and Related Infections

Hantavirus Update: A Glimpse Inside the Facilities Housing the Quarantined Cruise Ship Passengers

Preventing Tick Bites, Safely Removing Them, and When to Seek Medical Care

Clinical Insights Around the Hantavirus and the Cruise Ship Outbreak

AI at the Point of Care: How Clinical Knowledge Tools May Transform Antimicrobial Stewardship

Even With CDC Suppressing COVID-19 Vaccine Data, Clinicians Advocate for Their Value

Combining Technology and Novel Educator Touchpoints to Enable Greater Hepatitis C Screening

By Withholding Vaccine Data, Federal Government Proliferates its Anti-Vaccine Narrative

ACIP Charter Changes Moves Focus Away From Prevention and Value of Vaccines

Medical Professional Societies Leading the Vaccine Fight Against Federal Government

Starvation State Enables Staph aureus Survival Despite DNA Repair Loss, Challenging Antibiotics

Access Barriers Drive Suffering and Higher Costs for C diff Patients, Advocates Warn

AMR Action Fund Seeks to Revive Antibiotic Innovation With PASTEUR Act

As Congenital Syphilis Continues to Rise, Diagnostics and Education Play Key Roles

The Time to Create New Antibiotic Classes is Now: Addressing Antimicrobial Resistance Through AI

Meds to Beds: A Hepatitis C Treatment Program for Inpatient Postpartum Mothers

Pharma and AI Partnering to Drive Potential New Era in Antibiotic Development

A Path to Prevention: Precision Tracking of Staph in NICUs Reveals Hidden Transmission Risks

AI Drug Discovery: Finding Needles in a Haystack

2026 MAD-ID and SIDP Meeting: Creating a Synergistic Environment for the Upcoming Event

Early Genomic Surveillance Leads to a Decrease in Candida Auris Cases

Insights Around Incidence Rates and Evolving Diagnostics for Vector-Borne Diseases

Foundation’s Lobby Day is an Opportunity for C diff Patients and Caregivers to Meet With Congress

Upcoming National C diff Summit Will Feature Discussions on Access to Therapeutics, Prevention

The Microbe Manipulation Hypothesis: How Microbes May Influence Behavior and Free Will

How Clinical Labs Help Detect Outbreaks and Prevent Infectious Diseases

COVID-19 Variants and Vaccine Decisions Heading Into Fall

Danish Study Finds No Increased Risk from Aluminum-Containing Childhood Vaccines

Pandemics, Pathogens, and the Psychology of Violence

Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention

Carl Schmid on Supreme Court Ruling Upholding ACA Preventive Coverage & Its Impact on HIV Prevention

FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention

Merck’s Enflonsia Receives FDA Approval to Protect Infants From RSV During First Season

Precision in Practice: PK/PD Modeling Advances Infectious Disease Care

Microbiota-Based Therapy Improves Mental Quality of Life in rCDI Trial

Test Determines Between Bacterial and Viral Infections in 15 Minutes

FDA Approves F8 Formulation of Theratechnologies' Tesamorelin for HIV-Associated Lipodystrophy

Identifying Invasive Pneumococci in Pediatric Infections Utilizing Whole Genome Sequencing

Gilead's Once Yearly Lenacapavir Formulations Show Sustained Efficacy for HIV PrEP in Phase 1 Study

Retinal Biomarkers Reveal Vascular Changes in Long COVID

Emerging Threats and Key Knowledge From 2024 Trending Into 2025